BR9914532A - Processo de preparação de uma solução para pulverização nasal que contém um ou vários hormÈnios sexuais e uma ciclodextrina - Google Patents

Processo de preparação de uma solução para pulverização nasal que contém um ou vários hormÈnios sexuais e uma ciclodextrina

Info

Publication number
BR9914532A
BR9914532A BR9914532-4A BR9914532A BR9914532A BR 9914532 A BR9914532 A BR 9914532A BR 9914532 A BR9914532 A BR 9914532A BR 9914532 A BR9914532 A BR 9914532A
Authority
BR
Brazil
Prior art keywords
cyclodextrin
preparing
nasal spray
solution containing
spray solution
Prior art date
Application number
BR9914532-4A
Other languages
English (en)
Inventor
Gilles Fonknechten
Patrick Wuthrich
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of BR9914532A publication Critical patent/BR9914532A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Nanotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Reproductive Health (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Patente de Invenção: "PROCESSO DE PREPARAçãO DE UMA SOLUçãO PARA PULVERIZAçãO NASAL QUE CONTéM UM OU VáRIOS HORMÈNIOS SEXUAIS E UMA CICLODEXTRINA". A presente invenção refere-se a um processo de preparação de uma solução para pulverização nasal que contém um ou vários hormónios sexuais e uma ciclodextrina.
BR9914532-4A 1998-10-14 1999-10-13 Processo de preparação de uma solução para pulverização nasal que contém um ou vários hormÈnios sexuais e uma ciclodextrina BR9914532A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9812836A FR2784584B1 (fr) 1998-10-14 1998-10-14 Procede de preparation d'une solution pour pulverisation nasale contenant une ou plusieurs hormones sexuelles et une cyclodextrine
PCT/FR1999/002480 WO2000021503A1 (fr) 1998-10-14 1999-10-13 Procede de preparation d'une solution pour pulverisation nasale contenant une ou plusieurs hormones sexuelles et une cyclodextrine

Publications (1)

Publication Number Publication Date
BR9914532A true BR9914532A (pt) 2001-11-06

Family

ID=9531516

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9914532-4A BR9914532A (pt) 1998-10-14 1999-10-13 Processo de preparação de uma solução para pulverização nasal que contém um ou vários hormÈnios sexuais e uma ciclodextrina

Country Status (21)

Country Link
EP (1) EP1121100B1 (pt)
JP (1) JP3911125B2 (pt)
KR (1) KR100462441B1 (pt)
CN (1) CN1323198A (pt)
AT (1) ATE237310T1 (pt)
AU (1) AU756441B2 (pt)
BR (1) BR9914532A (pt)
CA (1) CA2346567C (pt)
DE (1) DE69907005T2 (pt)
DK (1) DK1121100T3 (pt)
EA (1) EA003069B1 (pt)
ES (1) ES2197672T3 (pt)
FR (1) FR2784584B1 (pt)
HK (1) HK1040201A1 (pt)
HU (1) HUP0103968A3 (pt)
NO (1) NO20011673D0 (pt)
NZ (1) NZ510776A (pt)
PL (1) PL347322A1 (pt)
PT (1) PT1121100E (pt)
WO (1) WO2000021503A1 (pt)
ZA (1) ZA200102961B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2827516B1 (fr) * 2001-07-19 2003-09-19 Servier Lab Composition pharmaceutique pour l'administration par voie nasale d'estradiol et de norethisterone
JPWO2005018607A1 (ja) * 2003-08-20 2007-11-01 味の素株式会社 溶解性を改善した医薬品製剤
GB2482868A (en) * 2010-08-16 2012-02-22 Franciscus Wilhelmus Henricus Maria Merkus A testosterone liquid spray formulation for oromucosal administration
MX2014004202A (es) * 2011-10-07 2015-03-05 Univ Florida State Res Found Uso post-agudo y profiláctico de progesterona para mejores resultados asociados con concusión.
CA2863500A1 (en) 2012-01-20 2013-07-25 Aratana Therapeutics Nv Eye drop composition
RU2753511C2 (ru) * 2017-05-31 2021-08-17 Аратана Терапьютикс, Инк. Композиция глазных капель

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8801670A (nl) * 1988-07-01 1990-02-01 Walter Adrianus Josephus Johan Farmaceutisch preparaat.
US5376645A (en) * 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
GB9012663D0 (en) * 1990-06-07 1990-08-01 Erba Carlo Spa Galenic formulations containing cyclodextrins
DE4207922A1 (de) * 1992-03-13 1993-09-23 Pharmatech Gmbh Wasserloesliche einschlussverbindungen und verfahren zu deren herstellung
BE1007402A5 (nl) * 1993-03-26 1995-06-06 Adir Nasale farmaceutische preparaten met progestagene stof.

Also Published As

Publication number Publication date
CA2346567C (fr) 2005-06-14
ZA200102961B (en) 2001-11-20
PL347322A1 (en) 2002-03-25
FR2784584A1 (fr) 2000-04-21
DE69907005T2 (de) 2004-03-18
HK1040201A1 (zh) 2002-05-31
EA003069B1 (ru) 2002-12-26
EP1121100A1 (fr) 2001-08-08
CN1323198A (zh) 2001-11-21
HUP0103968A3 (en) 2002-06-28
WO2000021503A1 (fr) 2000-04-20
EA200100316A1 (ru) 2002-02-28
PT1121100E (pt) 2003-07-31
CA2346567A1 (fr) 2000-04-20
AU756441B2 (en) 2003-01-16
ATE237310T1 (de) 2003-05-15
DK1121100T3 (da) 2003-07-21
AU6096799A (en) 2000-05-01
KR20010073214A (ko) 2001-07-31
EP1121100B1 (fr) 2003-04-16
NZ510776A (en) 2002-10-25
JP3911125B2 (ja) 2007-05-09
DE69907005D1 (de) 2003-05-22
FR2784584B1 (fr) 2002-09-20
NO20011673L (no) 2001-04-03
HUP0103968A2 (hu) 2002-04-29
NO20011673D0 (no) 2001-04-03
ES2197672T3 (es) 2004-01-01
JP2002527374A (ja) 2002-08-27
KR100462441B1 (ko) 2004-12-17

Similar Documents

Publication Publication Date Title
BR9712824A (pt) Composição oftálmica de fator neurotrófico, agente de tratamento de desordem funcional do nervo ótico e método para tratamento de desordem funcional do nervo ótico
BR9605426A (pt) Composições aquosas de aspersão e processo para aumentar o diâmetro médio de gotículas de aspersão e reduzir a deriva da aspersão de uma composição aquosa de aspersão
BR9804437A (pt) Compostos para a osteoporose
DE69024672D1 (de) Sprays zur Behandlung von Infektionen des Tractus Respiratorius
BRPI0409041A (pt) composição de esmalte para unhas, sistema solvente de esmalte para unhas e processos de fabricação de uma composição
BR0311242A (pt) Processo para preparar modafinil
BRPI9814894A (pt) processo para a preparação de ácidos 8-metóxi-quinolonocarboxílicos.
BR9914532A (pt) Processo de preparação de uma solução para pulverização nasal que contém um ou vários hormÈnios sexuais e uma ciclodextrina
BR9809608A (pt) Grânulo borrifado
BR9712141A (pt) Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
BR9813996A (pt) 2-arilbenzo[b]tiofenos úteis para o tratamento de sìndrome da privação de estrogênio
BR9712353A (pt) Agentes de limpeza
BR9912556A (pt) Triazolpiridinas para o tratamento de distúrbios trombóticos
BR9811515A (pt) Composição de revestimento curável através de radiação
BR9915123A (pt) Composição de uma substância farmaceuticamente ativa e dispensador
BR9812780A (pt) 2-aril-3-aroilbenzo[b]tiofenos úteis para o tratamento de sìndrome da perda de estrogênio
HU0003408D0 (en) Petrolatum-based nose ointment
BR0209842A (pt) Processo para a preparação de imipenem
DE69518149D1 (de) Intranasales Antimigränemittel
BR0007183A (pt) Isonipectoamidas para o tratamento de distúrbios mediados por integrina
BR9812351A (pt) Novo processo estereoseletivo para a preparação de análogas gabapentinas
BR9708963A (pt) Processo para a preparação de ivermectina
BR0009277A (pt) Processo de preparação de ácido propiÈnico de 3s-3-amino-3-arila e derivados deste
BR9909759A (pt) Processo para a fabricação de um composto
BR0107494A (pt) Processo e intermediários para o preparo de uma ciclohexilnitrila

Legal Events

Date Code Title Description
PC Transfer

Free format text: LES LABORATOIRES SERVIER (FR)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI

B15K Others concerning applications: alteration of classification

Ipc: B82Y 5/00 (2011.01), A61K 9/00 (2006.0